Resumen de negocios
Número de empleados: 7
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/11/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/02/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 3 713 | 0 | 0 | 100,00 % |
Acción B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Información de la empresa
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+42,83 % | 750 mil M | |
+34,11 % | 606 mil M | |
-5,70 % | 356 mil M | |
+18,06 % | 326 mil M | |
+4,63 % | 286 mil M | |
+17,02 % | 246 mil M | |
+9,26 % | 213 mil M | |
-4,21 % | 213 mil M | |
+2,43 % | 167 mil M |